May 6, 2015 | The Israeli medical device company Medi-Tate announced that it raised $2 million in a round led by Xenia Venture Capital. Medi-Tate specializes in the development of treatments of urethra and prostate diseases. Medi-Tate was founded in 2007 by CEO Ido Kilemnik and Rami Biran.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments